Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 254 citing Satoh: Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of.... (0.08 sec) 

The metabolic syndrome: time for a critical appraisal

- heartcarefound.org [PDF] 
R Kahn, J Buse, E Ferrannini, M Stern - Diabetologia, 2005 - Springer
Page 1. Diabetologia (2005) 48: 1684–1699 DOI 10.1007/s00125-005-1876-
2 REVIEW R. Kahn . J. Buse . E. Ferrannini . M. Stern The ...
Cited by 1188 - Related articles - BL Direct - All 52 versions

Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 …

- touchcardiology.com [PDF] 
T Mazzone, PM Meyer, SB Feinstein, MH … - Jama, 2006 - Am Med Assoc
Context Carotid artery intima-media thickness (CIMT) is a marker of coronary
atherosclerosis and independently predicts cardiovascular events, which are
increased in type 2 diabetes mellitus (DM). While studies of relatively ...
Cited by 221 - Related articles - BL Direct - All 13 versions

Mechanisms, pathophysiology, and therapy of arterial stiffness

- ahajournals.org
SJ Zieman, V Melenovsky, DA Kass - Arteriosclerosis, thrombosis, and vascular biology, 2005 - Am Heart Assoc
Arterial stiffness is a growing epidemic associated with increased risk of
cardiovascular events, dementia, and death. Decreased compliance of the central
vasculature alters arterial pressure and flow dynamics and impacts cardiac ...
Cited by 217 - Related articles - All 10 versions

A meta-analysis comparing the effect of thiazolidinediones on cardiovascular risk factors


E Chiquette, G Ramirez, R DeFronzo - Archives of internal medicine, 2004 - archinte.highwire.org
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ...
Cited by 199 - Related articles - BL Direct - All 6 versions

Pioglitazone decreases carotid intima-media thickness independently of glycemic control in …

- ahajournals.org
MR Langenfeld, T Forst, C Hohberg, P Kann, G … - Circulation, 2005 - Am Heart Assoc
Methods and Results— We compared the effects of pioglitazone-based therapy (45
mg/d) and glimepiride-based treatment (2.7±1.6 mg/d) for 12 and 24 weeks on
metabolic control (HbA 1c ), insulin resistance (homeostasis model ...
Cited by 188 - Related articles - All 14 versions

Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory …


GK Shetty, PA Economides, ES Horton, CS … - Diabetes Care, 2004 - Am Diabetes Assoc
RESULTS—In the cross-sectional study, we confirm prior positive correlations
of adiponectin with HDL and negative correlations with BMI, triglycerides,
C-reactive protein (CRP), and plasma activator inhibitor (PAI)-1 and report ...
Cited by 180 - Related articles - BL Direct - All 6 versions

Improvement of cardiovascular risk markers by pioglitazone is independent from glycemic …

- onlinejacc.org
A Pfützner, N Marx, G Lübben, M Langenfeld, … - Journal of the American College of Cardiology, 2005 - Elsevier
A total of 192 patients were enrolled into a six-month, prospective, open-label,
controlled clinical study. They were randomized to receive either pioglitazone
(45 mg) or glimepiride (1 to 6 mg, with the intent to optimize therapy). ...
Cited by 177 - Related articles - All 18 versions

Relationship between adiponectin and glycemic control, blood lipids, and inflammatory …

- diabetesjournals.org
MB Schulze, EB Rimm, I Shai, N Rifai, FB Hu - Diabetes Care, 2004 - Am Diabetes Assoc
RESULTS—Plasma adiponectin levels were positively correlated with HDL
cholesterol and negatively correlated with triglycerides, apolipoprotein B-100
(apoB 100 ), C-reactive protein (CRP), and fibrinogen. These associations ...
Cited by 118 - Related articles - BL Direct - All 9 versions

Prevention and treatment of the metabolic syndrome


SS Daskalopoulou, DP Mikhailidis, M Elisaf - Angiology, 2004 - ang.sagepub.com
The prevalence of the metabolic syndrome is increasing owing to lifestyle
changes leading to obesity. This syndrome is a complex association of several
interrelated abnormalities that increase the risk for cardiovascular ...
Cited by 107 - Related articles - BL Direct - All 5 versions

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in …

- ahajournals.org
PO Szapary, LAT Bloedon, FF Samaha, D Duffy, … - Arteriosclerosis, thrombosis, and vascular biology, 2006 - Am Heart Assoc
Methods and Results— Sixty nondiabetic adults with low HDL-C and MetSyn were
randomized to PIO or matching placebo for 12 weeks. PIO increased HDL-C by 15%
and 14% at 6 and 12 weeks, respectively, compared with placebo (P<0.001). ...
Cited by 106 - Related articles - All 10 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google